Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Sign In

{{'GLOBAL_MESSAGE_HEADLINE' | translate}}

{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}

{{'GLOBAL_MESSAGE_OR' | translate}}

{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}

{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}

{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}

{{'ELOQUA_BANNER_ACCEPT' | translate}}

{{'ELOQUA_BANNER_DECLINE' | translate}}

{{'MP_LVL1NAV_PRODUCTS_SERVICES' | translate}}

{{d.Title}}

{{psData[masterIndex].Blurb}}

{{n.Title}}

{{n.Blurb}}

{{countryCode}}

{{'SEARCH_MODAL_TITLE' | translate}}

Webinars

The Use of Chronic Erythrocytapheresis for Iron Overload Management in SCD

Here’s what you can expect:

Become familiar with chronic transfusion protocols for sickle cell disease (SCD)
Understand why iron overload is a consequence of simple transfusion therapy without chelation that can be managed with erythrocytapheresis
Review iron overload mitigation strategies
Gain new insight into best practices in chronic transfusion therapies

Duration: 40-minute recorded presentation, including a 20-minute Q&A

VIEW WEBINAR

About The Presenter:

Ross M. Fasano, MD

Pediatric Hematologist and Director of Apheresis,
Children’s Healthcare of Atlanta;
Assistant Professor, Department of Pathology and
Laboratory Medicine, Emory University School of Medicine

{{'MP_FOOTER_TBCT_COPYRIGHT' | translate}}

{{'SEARCH_MODAL_TITLE' | translate }}

{{s.Query|stripSpecialChars}}

{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }} {{'SEARCH_MODAL_ENLABEL' | translate }}

{{productCode.RefinementName}}

{{categoryCode.RefinementName}}

{{segmentCode.RefinementName}}

{{'SEARCH_MODAL_SHOW_BROWSE_RESULTS' | translate }}

{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}

{{$index+1}}. {{s.label}}